Table 1.
Demographic characteristics of ALL and AML patients based on age, gender, residency, and hematologic data
| Variables | Subgroups | ALL (%) | AML (%) |
|---|---|---|---|
| Age groups | 1 > 1-4.99 yrs 5-9.99 yrs 10-14.99 yrs |
1(0.6) 65 (36.3) 58(38.8) 45(25.1) |
1(1.6) 11 (17.2) 23 (35.9) 29 (45.3) |
| Sex | Male Female |
107 (59.8) 72 (40.2) |
34 (53.1) 30 (46.9) |
| Residency | Shiraz city Fars except Shiraz Other provinces |
63 (35.2) 68 (38) 48 (26.8) |
22 (34.4) 23 (35.9) 19 (29.7) |
| White blood cell | <25000 25000-49999 50000-99999 > 100000 |
170(95) 3(1.7) 3(1.7) 2(1.1) |
59(92.2) 2(3.1) - 3(4.7) |
| Hemoglobin | Abnormal Normal |
128 (71.5) 51 (28.5) |
54 (84.4) 10 (15.6) |
| Platelet | Thrombocytopenia Normal Thrombocytosis |
103 (57.5) 63 (35.2) 13 (7.3) |
52 (81.2) 11 (17.2) 1 (1.6) |
| Relapse | Yes No |
61 (34.1) 118 (56.9) |
20 (31.2) 44 (68.8) |
| Number of relapses | 0 1 ≥ 2 |
118 (65.9) 36 (20.1) 25 (14) |
44 (68.8) 9 (14.1) 11 (17.2) |
| Immunophenotype | Pre B-Cell Common AML T-Cell |
73 (40.8) 89 (49.7) - 17 (9.5) |
- - 64 (100) - |
| Status | Censored Death |
132 (73.7) 47 (26.3) |
49 (76.6) 15 (23.4) |
| Total cases | 179 (73.7) | 64 (26.3) | |
| Follow up duration (month) (mean±SD) | 28.5(16.3) | 27.4(15.7) |
ALL: Acute lymphoblastic leukemia; AML: Acute myeloblastic leukemia